Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.

Cancer treatment and research

Volumn 76, Issue , 1995, Pages 281-297

  Press, O W ^a   Eary, J F ^a   Appelbaum, F R ^a   Bernstein, I D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

AUTOTRANSPLANTATION; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; HUMAN; MULTIMODALITY CANCER THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; RADIOIMMUNOTHERAPY; RECURRENT DISEASE; REVIEW;

ANTIBODIES; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, B-CELL; RADIOIMMUNOTHERAPY; RECURRENCE; TRANSPLANTATION, AUTOLOGOUS;

MLCS; MLOWN;

EID: 0029198095     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-2013-9_13     Document Type: Review

References (68)